Japanese study to organize proper lifestyle modifications for metabolic syndrome (J-STOP-MetS): Design and method

Vascular Health and Risk Management

Volumn 4, Issue 2, 2008, Pages 415-420

  Munakata, Masanori ^a   Honma, Hiroki ^b   Akasi, Mitugu ^c   Araki, Takaharu ^d   Kawamura, Takahiko ^e   Kubota, Masashi ^f   Yokokawa, Tomoko ^g   Maruhashi, Akira ^h   Toyonaga, Toshihiro ⁱ  

^a TOHOKU ROSAI HOSPITAL   (Japan)

^b Iwamizawa Rosai Hospital   (Japan)

^c Japan Labour Health and Welfare Organization   (Japan)

^d TOKYO ROSAI HOSPITAL   (Japan)

^e Japan Labour Health and Welfare Organization   (Japan)

^f OSAKA ROSAI HOSPITAL   (Japan)

^g KANSAI ROSAI HOSPITAL   (Japan)

^h CHUGOKU ROSAI HOSPITAL   (Japan)

ⁱ KYUSHU ROSAI HOSPITAL   (Japan)

Author keywords

Diabetes; Dyslipidemia; Hypertension; J STOP MetS; Metabolic syndrome

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; GLUCOSE; LIPID;

ABDOMINAL FAT; ARTERIAL STIFFNESS; ARTICLE; BEHAVIOR MODIFICATION; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE MARKER; DYSLIPIDEMIA; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; JAPAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; METHODOLOGY; OBESITY; PATIENT COUNSELING; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; WAIST CIRCUMFERENCE; WEIGHT CONTROL;

CASE-CONTROL STUDIES; COUNSELING; CROSS-SECTIONAL STUDIES; EXERCISE THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; JAPAN; LIFE STYLE; MALE; METABOLIC SYNDROME X; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 44049093718     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abe T, Tsutsui H, Namba T. 1972. Studies on the self-rating questionnaire for the screening test of masked depression (SRQ-D) Japanese with English abstract]. J Jpn Psychosom Soc, 12:243-7.
2. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. 2005. The metabolic syndrome - a new worldwide definition. Lancet, 366:1059-62.
3. Baltali M, Gokcel A, Kiziltan HT, et al. 2003. Association between the metabolic syndrome and newly diagnosed coronary artery disease. Diabetes Nutr Metab, 16:169-75.
4. Bedogni G, Malavolti M, Severi S, et al. 2002. Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nut, 56:1143-48.
5. [CEDSMSJ] Committee to Evaluate Diagnostic Standard for Metabolic Syndrome in Japan. 2005. Nippon Naika Gakkai Zasshi94:794-809 (in Japanese).
6. Chandola T, Brunner E, Marmot M. 2006. Chronic stress at work and the metabolic syndrome: prospective study. BMJ, 332:521-5.
7. Cortez-Cooper MY, Supak JA, Tanaka H. 2003. A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol, 91:1519-22
8. Dansinger ML, Tastioni A, Wong JB, et al. 2007. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med, 147:41-50.
9. [DPPRG] Diabetes Prevention Program Research Group. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346:393-403.
10. [ECCODJ] The Examination Committee of Criteria for 'Obesity Disease' in Japan. 2002. New criteria for 'obesity disease' in Japan. Circ J, 66:987-92.
11. Haffner SM. 2006. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol, 97(2A):3A-11A.
12. Hara K, Matsushita Y, Horikoshi M, et al. 2006. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care, 29:1123-4.
13. Health Bureau Office of General Affairs Division-Lifestyle Diseases. 2004. National Health and Nutrition Examination Survey Results Overview [online; in Japanese]. Accessed on Dec 3, 2007. URL: http://www.mhlw.go.jp/houdou/2006/05/h0508-1a.html.
14. Karlsson B, Knutsson A, Lindahl B. 2001. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med, 58:747-52.
15. Kip KE, Marroquin OC, Kelley DE, et al. 2004. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation, 109:706-13.
16. Maeda S. 1985. A study on behavior pattern of patients with coronary heart disease: application of brief questionnaire in Japanese with English abstract]. Jap J Psychosom Med, 25:297-306.
17. Malavolti M, Mussi C, Poli M, et al. 2003. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol, 30:380-91.
18. Medici G, Mussi C, Fantuzzi AL, et al. 2005. Accuracy of eight-polar bioelectrical impedance analysis for the assessment of total and appendicular body composition in peritoneal dialysis patients. Eur J Clin Nutr, 59:932-7.
19. Miyawaki T, Hirata M, Moriyama K, et al. 2005. Metabolic syndrome in Japanese Diagnosed with visceral fat measurement by computed tomography. Proc Japan Acad, 81:1-9
20. Munakata M, Hiraizumi T, Tomiie T, et al. 1998. Psychobehavioral factors involved in the isolated office hypertension: comparison with stress-induced hypertension. J Hypertens, 16:419-22.
21. Munakata M, Ichii S, Nunokawa T, et al. 2001. Influence of night shift work on psychologic state and cardiovascular and neuroendocrine responses in healthy nurses. Hypertens Res, 24:25-31.
22. Munakata M, Ito N, Nunokawa T, et al. 2003. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens, 16:653-7.
23. Munro JF, Douglas JG. 1983. The management of obesity. Hum Nutr Clin Nutr, 37C:1-19.
24. Okamoto Y, Kihara S, Funahashi T, et al. 2006. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci, 110:267-78.
25. Okamura T, Moriyama Y, Kadowaki T, et al. 2004. Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with alpha-tocopherol in Japanese middle-aged male workers. Hypertens Res, 27:173-80.
26. Sacks FM, Svetkey LP, Vollmer WM, et al. 2001. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med, 344:3-10.
27. Sakamoto M. 2006. The situation of the epidemiology and management of obesity in Japan. Int J Vitam Nutr Res, 76:253-6.
28. Tomiyama H, Hirayama Y, Hashimoto H, et al. 2006. The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study. Hypertens Res, 29:673-8.
29. Yazaki Y, Kadowaki T. 2006. Combating diabetes and obesity in Japan. Nature Med, 12:73-4.
30. Yoshiike N, Kaneda F, Takimoto H. 2002. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr, 11(Suppl 8):S727-31.